Ironwood Pharmaceuticals Q2 Adj. EPS $0.14 Beats $0.04 Estimate, Sales $85.239M Beat $60.775M Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.04 by 250 percent. This is a 1300 percent increase over earnings of $0.01 per share
Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.04 by 250 percent. This is a 1300 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $85.239 million which beat the analyst consensus estimate of $60.775 million by 40.25 percent. This is a 9.70 percent decrease over sales of $94.396 million the same period last year.